The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.

<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated...

Full description

Bibliographic Details
Main Authors: Amani Thomas Mori, Eliangiringa Amos Kaale, Frida Ngalesoni, Ole Frithjof Norheim, Bjarne Robberstad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI
id doaj-aa495a98a1384a2da58609f3fa5db022
record_format Article
spelling doaj-aa495a98a1384a2da58609f3fa5db0222021-03-04T10:03:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8482410.1371/journal.pone.0084824The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.Amani Thomas MoriEliangiringa Amos KaaleFrida NgalesoniOle Frithjof NorheimBjarne Robberstad<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making.<h4>Methods</h4>This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data.<h4>Findings</h4>The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised.<h4>Conclusions</h4>Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Amani Thomas Mori
Eliangiringa Amos Kaale
Frida Ngalesoni
Ole Frithjof Norheim
Bjarne Robberstad
spellingShingle Amani Thomas Mori
Eliangiringa Amos Kaale
Frida Ngalesoni
Ole Frithjof Norheim
Bjarne Robberstad
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
PLoS ONE
author_facet Amani Thomas Mori
Eliangiringa Amos Kaale
Frida Ngalesoni
Ole Frithjof Norheim
Bjarne Robberstad
author_sort Amani Thomas Mori
title The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
title_short The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
title_full The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
title_fullStr The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
title_full_unstemmed The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
title_sort role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of tanzania.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description <h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making.<h4>Methods</h4>This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data.<h4>Findings</h4>The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised.<h4>Conclusions</h4>Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI
work_keys_str_mv AT amanithomasmori theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT eliangiringaamoskaale theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT fridangalesoni theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT olefrithjofnorheim theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT bjarnerobberstad theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT amanithomasmori roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT eliangiringaamoskaale roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT fridangalesoni roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT olefrithjofnorheim roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
AT bjarnerobberstad roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania
_version_ 1714806731629920256